R&D Partner Content 14th World ADC San Diego 2023 The World’s Longest-Standing & Most Comprehensive Antibody-Drug Conjugate Conference
R&D Partner Content Inaugural ADC Linker & Conjugation Summit The first industry-specific event helping you optimize your ADC’s chemistry
R&D Partner Content 3rd Rare & Genetic Kidney Disease Drug Development Summit Understand Disease Pathogenesis to Advance Genetic Targets & Technologies. Identify Disease Specific Biomarkers of Progression & Therapeutic Efficacy Confidently Recruit Patients & Execute Innovative Clinical Trials in Orphan Disease Populations.
R&D Partner Content 3rd Annual iPSC Derived-Cell Therapies Summit Accelerate Clinical Proof of Concept for the Future of Cell Therapy & Regenerative Medicine. Benchmark Clinical Translation to Advance Safe Differentiation, Gene-Editing and Manufacturing Efficiency to Fast-Track Regulatory Submissions.
Oncology Partner Content 3rd Annual Tumor-Myeloid-Directed Therapies Summit Activating the myeloid compartment to tackle tumor suppression. Benchmark Novel Targets, Identify Appropriate Biomarkers & Unravel Myeloid Biology to Accelerate Clinical Translation of Myeloid-Targeted Combination Approaches.
R&D Partner Content Gene Therapy Potency Assay Summit Identify, characterize and measure potency to ensure safety, efficacy & consistency of your Gene Therapy
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
